5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.92▲ | 5.89▲ | 5.84▲ | 6.02▼ | N/A |
MA10 | 5.85▲ | 5.84▲ | 5.97▼ | 5.99▼ | N/A |
MA20 | 6.01▼ | 6.09▼ | 6.24▼ | N/A | N/A |
MA50 | 6.39▼ | 6.09▼ | N/A | N/A | N/A |
MA100 | N/A | N/A | N/A | N/A | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.016▲ | -0.019▼ | -0.110▼ | N/A | N/A |
RSI | 42.105▼ | 45.710▼ | 46.538▼ | N/A | N/A |
STOCH | 58.680 | 43.661 | 17.413▼ | N/A | N/A |
WILL %R | -52.427 | -52.427 | -74.872 | N/A | N/A |
CCI | 22.720 | 14.257 | -33.210 | N/A | N/A |
Monday, November 25, 2024 07:00 AM
VANCOUVER, British Columbia, November 15, 2024--Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company ...
|
Thursday, November 14, 2024 04:00 PM
VANCOUVER, British Columbia, November 15, 2024--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG) ("Alpha Cognition", or the "Company"), a ...
|
Tuesday, November 12, 2024 06:22 AM
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
05/12/24 | 5.84 | 5.85 | 5.60 | 5.72 | 87,200 |
04/12/24 | 5.66 | 5.85 | 5.66 | 5.744 | 44,400 |
03/12/24 | 6.10 | 6.421 | 5.70 | 5.90 | 307,900 |
02/12/24 | 6.65 | 6.98 | 5.91 | 6.10 | 144,091 |
29/11/24 | 6.79 | 6.883 | 6.521 | 6.62 | 17,200 |
27/11/24 | 6.00 | 6.80 | 5.925 | 6.67 | 399,008 |
26/11/24 | 5.84 | 5.9999 | 5.72 | 5.95 | 127,942 |
25/11/24 | 5.75 | 5.80 | 5.62 | 5.725 | 237,200 |
22/11/24 | 5.77 | 5.80 | 5.68 | 5.72 | 52,200 |
21/11/24 | 5.85 | 5.85 | 5.70 | 5.754 | 102,100 |
|
|
||||
|
|
||||
|
|